Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)

NCT01862315 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Intrahepatic Cholangiocarcinoma
Peripheral Cholangiocarcinoma
Cholangiolar Carcinoma
Cholangiocellular Carcinoma

Interventions

DRUG: Floxuridine (FUDR)
DRUG: dexamethasone
DRUG: Gemcitabine
DRUG: Oxaliplatin
OTHER: MRI
OTHER: Research blood draws

Sponsor

Memorial Sloan Kettering Cancer Center